Spyglass Capital Management LLC

Q2 2026 13F-HR Holdings

Location
Greenbrae, CA
Holdings as of
6/30/2026
Date filed
8/14/2026
Form type
13F-HR
Num holdings
25
Total value ($000)
$1,847,373
Net value change ($000)
+434,867 (30.8%)
New positions
4
Sold out positions
4
Turnover %
23.5%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/15/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
QXO 62,961 NEW
Ascendis Pharma AS 57,451 NEW
CRDO 53,619 96.5%
MKSI 52,720 NEW
AFRM 49,243 64.7%
CHYM 45,464 187.1%
ILMN 40,599 101.3%
FPS 39,401 NEW
MEDP 36,971 138.1%
APP 32,133 48.5%
Top Reduces (Value $000, Stocks/ETFs)
ASND -84,166 -100.0%
KNSL -46,817 -100.0%
NCNO -46,217 -100.0%
RBLX -44,116 -100.0%
PCOR -14,537 -25.4%
HUBS -8,850 -11.5%
CDNS -5,789 -8.9%
APG -2,260 -4.4%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type